Establishment of a rat model of early-stage liver failure and Th17/Treg imbalance
-
摘要:
目的研究肝衰竭前期大鼠模型建立的方法以及地塞米松和胸腺肽干预前后辅助性T淋巴细胞(Th)17、调节性T淋巴细胞(Treg)和Th17/Treg的变化。方法 64只大鼠随机分为四氯化碳(CCl4)组和脂多糖(LPS)联合D-氨基半乳糖(D-Gal N)组,分别建立肝衰竭前期大鼠模型。通过观察大鼠活动,肝功能以及全血Th17、Treg的变化,评价成模效果。并用地塞米松和胸腺肽进行干预,观察干预效果。计量资料组间比较采用t检验,组内比较采用配对t检验。结果造模组血清ALT、AST、TBil水平显著升高,与对照组相比差异均有统计学意义(CCl4组:t值分别为-3.95、-3.60、-3.57,P值分别为0.006、0.009、0.009;D-Gal N联合LPS组:t值分别为-10.56、-9.63、-11.82,P值均<0.001)。造模后大鼠外周血Th17均上升、Treg均下降,Th17/Treg失衡。造模组大鼠肝组织病理符合肝衰竭前期改变。地塞米松干预后大鼠Th17下降(CCl4组:0.830±0.224 vs 0.580±0.105,t=3.25,P=0.014;D-Gal N联...
Abstract:Objective To investigate the methods for establishing a rat model of early- stage liver failure and the changes in Th17,Treg,and Th17 / Treg after dexamethasone and thymosin interventions. Methods A total of 64 rats were randomly divided into carbon tetrachloride( CCl4) group and endotoxin [lipopolysaccharide( LPS) ]/D- galactosamine( D- Gal N) combination group to establish the rat model of early- stage liver failure. The activities of the rats and changes in liver function and whole blood Th17 and Treg were observed to evaluate the effectiveness of the rat model. Dexamethasone and thymosin were used for intervention and related effects were observed. The t- test was used for comparison of continuous data between groups,and the paired t- test was used for comparison of continuous data within one group.Results The serum levels of alanine aminotransferase,aspartate aminotransferase,and total bilirubin showed significant increases in the model groups and were significantly different from those in the control group( CCl4group: t =- 3. 95,- 3. 60,and- 3. 57,P = 0. 006,0. 009,and 0. 009; LPS / D- Gal N combination group: t =- 10. 56,- 9. 63,and- 11. 82,all P < 0. 001). After the model was established,the rats showed an increase in Th17,a reduction in Treg,and Th17 / Treg imbalance. The liver pathology in the rats in the model groups was consistent with the changes in early- stage liver failure. After dexamethasone intervention,the rats showed a reduction in Th17( CCl4group: 0. 830 ± 0. 224 vs 0. 580 ± 0. 105,t = 3. 25,P = 0. 014; LPS / D- Gal N combination group: 1. 301 ± 0. 163 vs 0. 921 ±0. 141,t = 4. 12,P = 0. 004),an increase in Treg( CCl4group: 0. 317 ± 0. 076 vs 0. 385 ± 0. 083,t =- 11. 13,P < 0. 001; LPS / D-Gal N combination group: 0. 351 ± 0. 110 vs 0. 570 ± 0. 119,t =- 4. 06,P = 0. 005),and Th17 / Treg rebalance( CCl4group: 2. 201 ±0. 556 vs 1. 511 ± 0. 534,t = 3. 56,P = 0. 09; LPS / D- Gal N combination group: 3. 699 ± 0. 976 vs 1. 619 ± 0. 423,t = 3. 82,P = 0. 07).After thymosin intervention,the rats showed an increase in Th17( CCl4group: 1. 161 ± 0. 219 vs 1. 270 ± 0. 230,t =- 5. 74,P = 0. 001;LPS / D- Gal N combination group: 0. 451 ± 0. 095 vs 0. 929 ± 0. 130,t =- 8. 61,P < 0. 001),a reduction in Treg( CCl4group: 0. 643 ±0. 100 vs 0. 615 ± 0. 092,t = 2. 66,P = 0. 032; LPS / D- Gal N combination group: 0. 200 ± 0. 085 vs 0. 161 ± 0. 095,t = 3. 15,P =0. 016),and aggravation of Th17 / Treg imbalance( CCl4group: 1. 799 ± 0. 625 vs 2. 071 ± 0. 587,t =- 6. 47,P < 0. 001; LPS / D- Gal N combination group: 2. 244 ± 0. 634 vs 5. 770 ± 1. 455,t =- 11. 72,P < 0. 001). Conclusion The two methods of CCl4 and LPS / D-Gal N combination can successfully establish the rat model of early- stage liver failure with no deaths,and liver histological results and serum biochemical changes are in consistence with the changes in early- stage liver failure. Dexamethasone intervention helps to improve Th17 /Treg imbalance,while thymosin intervention causes aggravation of Th17 / Treg imbalance.
-
Key words:
- liver failure /
- carbon tetrachloride /
- lipopolysaccharide /
- galactosamine /
- disease models,animal
-
[1]LAI LY,YANG X,XU XQ,et al.Establishment of animal model with acute hepatic failure caused by lavage carbon tetrachloride[J].China J Modern Med,2005,11(11):1655-1657.(in Chinese)赖力英,杨旭,许向青,等.四氯化碳诱导大鼠急性肝功能衰竭动物模型的建立[J].中国现代医学杂志,2005,11(11):1655-1657. [2]TAN XH,XUE LY,ZHOU Y,et al.Preparation of rat model of acute liver failure with acute liver failure[J].Chin Hepatol,2013,18(12):820-822.(in Chinese)谭晓慧,薛璐瑜,周跃,等.大鼠慢加急性肝功能衰竭模型的制备[J].肝脏,2013,18(12):820-822. [3]LIU KX.Basis and animal models of liver disease[M].Beijing:China Medical Science Press,2003:156-159.(in Chinese)刘克辛.肝疾患基础及其实验动物模型[M].北京:中国医药科技出版社,2003:156-159. [4]GOLDANI HA,MATTE US,RAMOS AR,et al.The role of food restriction on CCl4-induced cirrhosis model in rats[J].Exp Toxicol Pathol,2007,58(5):331-337. [5]HIJIKAWA T,KAIBORI M,UCHIDA Y,et al.Insulin-like growth factor 1 prevents liver injury through the inhibition of TNFalpha and iN OS induction in D-galactosamine and LPS-treated rats.[J].Shock,2008,29(6):740-747. [6]RAHMAN TM,HODGSON HJF.Animal models of acute hepatic failure[J].Int J Clin Exp Patho,2000,81(2):145-157. [7]BAI Y,LENG J.The role of HSCs and relative cytokines IFN,TNF during liver fibrosis[J].Med Recapitul,2009,15(30):392-394.(in Chinese)白玉,冷静.肝星形细胞及相关细胞因子IFN、TNF在肝纤维化形成中的作用[J].医学综述,2009,15(30):392-394. [8]WANG XJ,ZHANG XP,NING Q.Immune-mediated liver failure[J].J Clin Hepatol,2014,10(10):984-991.(in Chinese)王晓晶,张小平,宁琴.肝衰竭的免疫发病机制[J].临床肝胆病杂志,2014,10(10):984-991. [9]ZHANG W,LUO FJ,ZHOU JJ,et al.Research progress on Th17 cells[J].J Zhejiang Univ:Med Sci,2007,36(6):620-625.(in Chinese)张炜,罗芳军,周娇娇,等.Th17细胞的研究进展[J].浙江大学学报:医学版,2007,36(6):620-625. [10]ZHU JG.The research of treg cells:progress and challenge[J].World J Cardiov Dis,2015,5(6):150-165. [11]SERAFINO A,PIERIMARCHI P,PICA F,et al.Thymosinα1 as a stimulatory agent of innate cell-mediated immune response[J].Ann N Y Acad Sci,2012,1270(4):13-20. [12]LYU H,PAN ZQ,HU SY,et al.Relationship between CD4+CD25+Treg cells,Th17 cells and IL-6 and the prognosis of hepatitis B virus-related acute-on-chronic liver failure:a meta-analysis[J].Chin J Hepatol,2014,22(7):493-498.(in Chinese)吕红,潘宗琴,胡世芸,等.CD4+CD25+Treg细胞和Th17细胞及白细胞介6与HBV相关慢加急性肝衰竭预后关系的Meta分析[J].中华肝脏病杂志,2014,22(7):493-498. -

计量
- 文章访问数: 2192
- HTML全文浏览量: 45
- PDF下载量: 521
- 被引次数: 0